These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 753125)
1. [Rubella, measles and mumps. Epidemiology and prophylaxis (author's transl)]. Zardi O Ann Sclavo; 1978; 20(4):487-509. PubMed ID: 753125 [TBL] [Abstract][Full Text] [Related]
2. [Epidemiologic study of measles, rubella and mumps with regard to the possibility of their control by immunization]. Rodríguez Borrego MJ; García León J; Bolumar F; Nájera E Rev Sanid Hig Publica (Madr); 1985; 59(1-2):117-25. PubMed ID: 4059834 [No Abstract] [Full Text] [Related]
3. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251 [TBL] [Abstract][Full Text] [Related]
4. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population]. Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596 [TBL] [Abstract][Full Text] [Related]
5. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases. Böttiger M; Christenson B; Strandell A; Romanus V Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776 [TBL] [Abstract][Full Text] [Related]
6. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region]. Salvadori P Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974 [No Abstract] [Full Text] [Related]
7. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme. Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C Microbios; 1996; 88(356):143-8. PubMed ID: 9141711 [TBL] [Abstract][Full Text] [Related]
8. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC; Burgess MA; O'Brien ED Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
9. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123 [TBL] [Abstract][Full Text] [Related]
10. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Edmunds WJ; Gay NJ; Kretzschmar M; Pebody RG; Wachmann H; Epidemiol Infect; 2000 Dec; 125(3):635-50. PubMed ID: 11218214 [TBL] [Abstract][Full Text] [Related]
11. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related]
12. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca]. Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414 [TBL] [Abstract][Full Text] [Related]
13. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid]. Rodríguez ML; Martínez D; Santos-Sancho JM; Borda JR; Orero A Rev Esp Quimioter; 2014 Jun; 27(2):98-101. PubMed ID: 24940889 [TBL] [Abstract][Full Text] [Related]
15. [The epidemiological impact of vaccination strategies in the Lazio Region]. Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423 [No Abstract] [Full Text] [Related]
16. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps. Ferson MJ; Robertson PW; Whybin LR Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422 [TBL] [Abstract][Full Text] [Related]
17. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II. Knutsson N; Jansson UB; Alm B Vaccine; 2006 Jul; 24(31-32):5800-5. PubMed ID: 16765490 [TBL] [Abstract][Full Text] [Related]
18. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102 [TBL] [Abstract][Full Text] [Related]
19. [Health and economic benefits of mandatory regular vaccination in Slovakia. IV. Measles, rubella and mumps]. Hudecková H; Straka S; Avdicová M; Rusnáková S Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):31-5. PubMed ID: 11233671 [TBL] [Abstract][Full Text] [Related]
20. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]